Rank | Gene Set | Z-score |
---|---|---|
1 | vocalization behavior (GO:0071625) | 5.36548459 |
2 | desmosome organization (GO:0002934) | 4.89791785 |
3 | neuron cell-cell adhesion (GO:0007158) | 4.86561901 |
4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.76946826 |
5 | protein localization to synapse (GO:0035418) | 4.53011961 |
6 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.48751680 |
7 | exploration behavior (GO:0035640) | 4.43830266 |
8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.38113786 |
9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.33765126 |
10 | positive regulation of mitochondrial fission (GO:0090141) | 4.31059479 |
11 | glutamate secretion (GO:0014047) | 4.30225962 |
12 | positive regulation of action potential (GO:0045760) | 4.26080922 |
13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.17291438 |
14 | synaptic vesicle exocytosis (GO:0016079) | 4.15969280 |
15 | dendritic spine morphogenesis (GO:0060997) | 4.15592617 |
16 | locomotory exploration behavior (GO:0035641) | 4.08546585 |
17 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.95683957 |
18 | keratinocyte proliferation (GO:0043616) | 3.91289603 |
19 | establishment of mitochondrion localization (GO:0051654) | 3.86736522 |
20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.84211507 |
21 | neuron recognition (GO:0008038) | 3.81158746 |
22 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.76215072 |
23 | nucleobase catabolic process (GO:0046113) | 3.76001054 |
24 | positive regulation of vesicle fusion (GO:0031340) | 3.73274720 |
25 | layer formation in cerebral cortex (GO:0021819) | 3.73007298 |
26 | tachykinin receptor signaling pathway (GO:0007217) | 3.72474199 |
27 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.70499064 |
28 | synaptic vesicle maturation (GO:0016188) | 3.70416310 |
29 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.65129972 |
30 | axonal fasciculation (GO:0007413) | 3.64588005 |
31 | neuronal action potential propagation (GO:0019227) | 3.63004060 |
32 | glutamate receptor signaling pathway (GO:0007215) | 3.62266907 |
33 | positive regulation of synapse maturation (GO:0090129) | 3.59627384 |
34 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.57359694 |
35 | postsynaptic membrane organization (GO:0001941) | 3.54019812 |
36 | protein localization to cilium (GO:0061512) | 3.51057022 |
37 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.47534237 |
38 | regulation of vesicle fusion (GO:0031338) | 3.46771636 |
39 | retinal ganglion cell axon guidance (GO:0031290) | 3.46411220 |
40 | cochlea development (GO:0090102) | 3.42492331 |
41 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.41807609 |
42 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.39786901 |
43 | neurotransmitter secretion (GO:0007269) | 3.39554779 |
44 | presynaptic membrane assembly (GO:0097105) | 3.33768456 |
45 | innervation (GO:0060384) | 3.26980524 |
46 | transmission of nerve impulse (GO:0019226) | 3.24144562 |
47 | exogenous drug catabolic process (GO:0042738) | 3.22578132 |
48 | neuron-neuron synaptic transmission (GO:0007270) | 3.22142626 |
49 | positive regulation of membrane potential (GO:0045838) | 3.13649465 |
50 | neuronal ion channel clustering (GO:0045161) | 3.13632135 |
51 | regulation of action potential (GO:0098900) | 3.13193676 |
52 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.11701442 |
53 | auditory behavior (GO:0031223) | 3.10712296 |
54 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.10147928 |
55 | negative regulation of heart rate (GO:0010459) | 3.09158087 |
56 | chemosensory behavior (GO:0007635) | 3.09092988 |
57 | regulation of synapse structural plasticity (GO:0051823) | 3.09031315 |
58 | glycosphingolipid biosynthetic process (GO:0006688) | 3.08474673 |
59 | hippocampus development (GO:0021766) | 3.08398210 |
60 | cell migration in hindbrain (GO:0021535) | 3.07937188 |
61 | synaptic transmission, glutamatergic (GO:0035249) | 3.06564167 |
62 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.06441104 |
63 | regulation of glucocorticoid secretion (GO:2000849) | 3.05317210 |
64 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.05075645 |
65 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.02798561 |
66 | regulation of synaptic vesicle transport (GO:1902803) | 3.01697811 |
67 | response to histamine (GO:0034776) | 3.01543617 |
68 | negative regulation of microtubule polymerization (GO:0031115) | 3.01362420 |
69 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.00898394 |
70 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.00898394 |
71 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.00510384 |
72 | intraciliary transport (GO:0042073) | 2.99692488 |
73 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.99413076 |
74 | cellular potassium ion homeostasis (GO:0030007) | 2.99164527 |
75 | proline transport (GO:0015824) | 2.99091455 |
76 | glucosamine-containing compound catabolic process (GO:1901072) | 2.98301998 |
77 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.98013099 |
78 | positive regulation of synapse assembly (GO:0051965) | 2.97748901 |
79 | dendritic spine organization (GO:0097061) | 2.97647818 |
80 | ephrin receptor signaling pathway (GO:0048013) | 2.97543991 |
81 | presynaptic membrane organization (GO:0097090) | 2.96332171 |
82 | nonmotile primary cilium assembly (GO:0035058) | 2.95518826 |
83 | cellular response to ammonium ion (GO:0071242) | 2.94997650 |
84 | neurotransmitter transport (GO:0006836) | 2.94434624 |
85 | gamma-aminobutyric acid transport (GO:0015812) | 2.94263860 |
86 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.93801996 |
87 | synapse assembly (GO:0007416) | 2.92454350 |
88 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.92362015 |
89 | olfactory bulb development (GO:0021772) | 2.91913460 |
90 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.91639818 |
91 | regulation of dendritic spine development (GO:0060998) | 2.90797358 |
92 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.87955417 |
93 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.85315226 |
94 | regulation of feeding behavior (GO:0060259) | 2.84543835 |
95 | establishment of skin barrier (GO:0061436) | 2.83832116 |
96 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.82929988 |
97 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.82929988 |
98 | regulation of postsynaptic membrane potential (GO:0060078) | 2.82415121 |
99 | mechanosensory behavior (GO:0007638) | 2.81287440 |
100 | neural tube formation (GO:0001841) | 2.79661461 |
101 | organelle transport along microtubule (GO:0072384) | 2.79656174 |
102 | sequestering of actin monomers (GO:0042989) | 2.79541824 |
103 | central nervous system neuron axonogenesis (GO:0021955) | 2.79503647 |
104 | negative regulation of dendrite development (GO:2000171) | 2.79020650 |
105 | regulation of mitochondrial fission (GO:0090140) | 2.78126710 |
106 | cullin deneddylation (GO:0010388) | 2.77158143 |
107 | intraspecies interaction between organisms (GO:0051703) | 2.75491122 |
108 | social behavior (GO:0035176) | 2.75491122 |
109 | response to auditory stimulus (GO:0010996) | 2.75033190 |
110 | drug catabolic process (GO:0042737) | 2.74433130 |
111 | long-term synaptic potentiation (GO:0060291) | 2.73981119 |
112 | dendrite morphogenesis (GO:0048813) | 2.73079369 |
113 | neurofilament cytoskeleton organization (GO:0060052) | 2.73040646 |
114 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.72741150 |
115 | acidic amino acid transport (GO:0015800) | 2.71588808 |
116 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.71449702 |
117 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.71276815 |
118 | mitochondrion transport along microtubule (GO:0047497) | 2.71276815 |
119 | cytoskeleton-dependent intracellular transport (GO:0030705) | 2.71084627 |
120 | long-term memory (GO:0007616) | 2.70681896 |
121 | short-term memory (GO:0007614) | 2.69711949 |
122 | synaptic vesicle endocytosis (GO:0048488) | 2.69181830 |
123 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.69160354 |
124 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.67956864 |
125 | keratinocyte development (GO:0003334) | 2.67222917 |
126 | C4-dicarboxylate transport (GO:0015740) | 2.66999765 |
127 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.66788570 |
128 | regulation of synaptic plasticity (GO:0048167) | 2.66666145 |
129 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.66511095 |
130 | behavioral response to cocaine (GO:0048148) | 2.66468511 |
131 | axon extension (GO:0048675) | 2.66195268 |
132 | cerebellar granule cell differentiation (GO:0021707) | 2.66163862 |
133 | serotonin metabolic process (GO:0042428) | 2.65694882 |
134 | behavioral response to nicotine (GO:0035095) | 2.65442117 |
135 | establishment of vesicle localization (GO:0051650) | 2.64999916 |
136 | glutathione biosynthetic process (GO:0006750) | 2.64926600 |
137 | behavioral fear response (GO:0001662) | 2.64683844 |
138 | behavioral defense response (GO:0002209) | 2.64683844 |
139 | synaptic vesicle transport (GO:0048489) | 2.64681677 |
140 | establishment of synaptic vesicle localization (GO:0097480) | 2.64681677 |
141 | regulation of synapse maturation (GO:0090128) | 2.64557876 |
142 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.64192024 |
143 | synapse organization (GO:0050808) | 2.63894334 |
144 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.63281855 |
145 | regulation of ruffle assembly (GO:1900027) | 2.63174756 |
146 | regulation of neurotransmitter levels (GO:0001505) | 2.61994791 |
147 | spinal cord development (GO:0021510) | 2.61915866 |
148 | regulation of phospholipase A2 activity (GO:0032429) | 2.61790194 |
149 | learning (GO:0007612) | 2.60984878 |
150 | microtubule-based transport (GO:0010970) | 2.60842914 |
151 | limb bud formation (GO:0060174) | 2.60810518 |
152 | organic cation transport (GO:0015695) | 2.60056231 |
153 | startle response (GO:0001964) | 2.58575538 |
154 | somite development (GO:0061053) | 2.58207880 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.17155142 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.94129450 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.49761935 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.08883577 |
5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.03759116 |
6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99681804 |
7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.89049163 |
8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.71675389 |
9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.67496561 |
10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.63115950 |
11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.63115950 |
12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.61891729 |
13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.54321851 |
14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.50368041 |
15 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.44296762 |
16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.40355849 |
17 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.38160339 |
18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.28349559 |
19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.28164340 |
20 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.24355705 |
21 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.23530812 |
22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.17838236 |
23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10199153 |
24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.06560342 |
25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.05182747 |
26 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.01516814 |
27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.91859209 |
28 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.91492660 |
29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.88279427 |
30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88056907 |
31 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.80815079 |
32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.78077928 |
33 | EWS_26573619_Chip-Seq_HEK293_Human | 1.76748221 |
34 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.75420105 |
35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.73205379 |
36 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.69072071 |
37 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.67477883 |
38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.66440004 |
39 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.63859427 |
40 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.60103465 |
41 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.58765897 |
42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55605213 |
43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.54738643 |
44 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.52799199 |
45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52303133 |
46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52253884 |
47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.50734019 |
48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47950478 |
49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44435574 |
50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44174952 |
51 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43441400 |
52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.41068331 |
53 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37374162 |
54 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.36193250 |
55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35964272 |
56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34864848 |
57 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33519287 |
58 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.32822445 |
59 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31038749 |
60 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.29348619 |
61 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.29320826 |
62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28294925 |
63 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.27275768 |
64 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26914827 |
65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25549221 |
66 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22630848 |
67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22258878 |
68 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.19381908 |
69 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18725720 |
70 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18665636 |
71 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.17552918 |
72 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16026866 |
73 | JUN_21703547_ChIP-Seq_K562_Human | 1.15580675 |
74 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.15544361 |
75 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.15541248 |
76 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15002199 |
77 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.14847036 |
78 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14483009 |
79 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14450962 |
80 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.14086968 |
81 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.13174986 |
82 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.12908043 |
83 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12648395 |
84 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11880211 |
85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11550413 |
86 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.09643499 |
87 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08534304 |
88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07914103 |
89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06868347 |
90 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06540066 |
91 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06045218 |
92 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.05637526 |
93 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03926188 |
94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03156563 |
95 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.02981468 |
96 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02862459 |
97 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.02433075 |
98 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01775930 |
99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01775930 |
100 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01409909 |
101 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01135053 |
102 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00680095 |
103 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00679999 |
104 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99861935 |
105 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99721825 |
106 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.99492988 |
107 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99325869 |
108 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99144806 |
109 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99062962 |
110 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98315467 |
111 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97893586 |
112 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.96321064 |
113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95813255 |
114 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.94740875 |
115 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94309472 |
116 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.93929834 |
117 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93666899 |
118 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92403113 |
119 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91865684 |
120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91597420 |
121 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.91182056 |
122 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90968336 |
123 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90456921 |
124 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90419174 |
125 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89114204 |
126 | AR_19668381_ChIP-Seq_PC3_Human | 0.88963353 |
127 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88461899 |
128 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88243616 |
129 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.87591337 |
130 | KDM2B_26808549_Chip-Seq_REH_Human | 0.87056707 |
131 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85861324 |
132 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.85178742 |
133 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.84827822 |
134 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84713864 |
135 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.84223681 |
136 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.84223681 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.68208778 |
2 | MP0003880_abnormal_central_pattern | 4.07265849 |
3 | MP0003635_abnormal_synaptic_transmissio | 3.41924476 |
4 | MP0004270_analgesia | 3.16867866 |
5 | MP0002063_abnormal_learning/memory/cond | 2.85453467 |
6 | MP0009745_abnormal_behavioral_response | 2.75584032 |
7 | MP0002796_impaired_skin_barrier | 2.74752531 |
8 | MP0009046_muscle_twitch | 2.64888865 |
9 | MP0001968_abnormal_touch/_nociception | 2.61854562 |
10 | MP0002572_abnormal_emotion/affect_behav | 2.50080420 |
11 | MP0002064_seizures | 2.49429495 |
12 | MP0002822_catalepsy | 2.48839447 |
13 | MP0003941_abnormal_skin_development | 2.48664968 |
14 | MP0000778_abnormal_nervous_system | 2.41713382 |
15 | MP0002102_abnormal_ear_morphology | 2.28420571 |
16 | MP0006276_abnormal_autonomic_nervous | 2.25543045 |
17 | MP0009780_abnormal_chondrocyte_physiolo | 2.19289319 |
18 | MP0002736_abnormal_nociception_after | 2.16734049 |
19 | MP0001440_abnormal_grooming_behavior | 2.05538076 |
20 | MP0009379_abnormal_foot_pigmentation | 2.04985582 |
21 | MP0003121_genomic_imprinting | 2.00415812 |
22 | MP0002184_abnormal_innervation | 1.99655966 |
23 | MP0002734_abnormal_mechanical_nocicepti | 1.97801027 |
24 | MP0001501_abnormal_sleep_pattern | 1.97039022 |
25 | MP0001486_abnormal_startle_reflex | 1.95126978 |
26 | MP0002735_abnormal_chemical_nociception | 1.83216063 |
27 | MP0002557_abnormal_social/conspecific_i | 1.81631981 |
28 | MP0002272_abnormal_nervous_system | 1.79834964 |
29 | MP0002733_abnormal_thermal_nociception | 1.73588890 |
30 | MP0004885_abnormal_endolymph | 1.72659791 |
31 | MP0004043_abnormal_pH_regulation | 1.66917964 |
32 | MP0005423_abnormal_somatic_nervous | 1.64916848 |
33 | MP0002067_abnormal_sensory_capabilities | 1.64794074 |
34 | MP0001984_abnormal_olfaction | 1.61429910 |
35 | MP0004381_abnormal_hair_follicle | 1.59810513 |
36 | MP0005499_abnormal_olfactory_system | 1.57401768 |
37 | MP0005394_taste/olfaction_phenotype | 1.57401768 |
38 | MP0004858_abnormal_nervous_system | 1.55430476 |
39 | MP0001502_abnormal_circadian_rhythm | 1.55334914 |
40 | MP0002234_abnormal_pharynx_morphology | 1.55319413 |
41 | MP0005248_abnormal_Harderian_gland | 1.53402988 |
42 | MP0004019_abnormal_vitamin_homeostasis | 1.51847548 |
43 | MP0003221_abnormal_cardiomyocyte_apopto | 1.51344762 |
44 | MP0005501_abnormal_skin_physiology | 1.45225804 |
45 | MP0003879_abnormal_hair_cell | 1.45161487 |
46 | MP0008995_early_reproductive_senescence | 1.43543610 |
47 | MP0002638_abnormal_pupillary_reflex | 1.42751974 |
48 | MP0001765_abnormal_ion_homeostasis | 1.42559824 |
49 | MP0003329_amyloid_beta_deposits | 1.42035462 |
50 | MP0001970_abnormal_pain_threshold | 1.39446688 |
51 | MP0002751_abnormal_autonomic_nervous | 1.38863672 |
52 | MP0000049_abnormal_middle_ear | 1.35981257 |
53 | MP0004811_abnormal_neuron_physiology | 1.32442128 |
54 | MP0005253_abnormal_eye_physiology | 1.30879504 |
55 | MP0008789_abnormal_olfactory_epithelium | 1.26982870 |
56 | MP0004133_heterotaxia | 1.26976528 |
57 | MP0001905_abnormal_dopamine_level | 1.26409553 |
58 | MP0005187_abnormal_penis_morphology | 1.25311939 |
59 | MP0003011_delayed_dark_adaptation | 1.23942959 |
60 | MP0010234_abnormal_vibrissa_follicle | 1.23533679 |
61 | MP0002837_dystrophic_cardiac_calcinosis | 1.21818000 |
62 | MP0003938_abnormal_ear_development | 1.19798661 |
63 | MP0002254_reproductive_system_inflammat | 1.18663910 |
64 | MP0000569_abnormal_digit_pigmentation | 1.18035210 |
65 | MP0010771_integument_phenotype | 1.17556204 |
66 | MP0002653_abnormal_ependyma_morphology | 1.16078071 |
67 | MP0002882_abnormal_neuron_morphology | 1.14884864 |
68 | MP0008961_abnormal_basal_metabolism | 1.14863120 |
69 | MP0008569_lethality_at_weaning | 1.14347578 |
70 | MP0003122_maternal_imprinting | 1.14198868 |
71 | MP0006072_abnormal_retinal_apoptosis | 1.13330769 |
72 | MP0005551_abnormal_eye_electrophysiolog | 1.13269918 |
73 | MP0005645_abnormal_hypothalamus_physiol | 1.13063416 |
74 | MP0006292_abnormal_olfactory_placode | 1.13022132 |
75 | MP0000383_abnormal_hair_follicle | 1.12868078 |
76 | MP0000538_abnormal_urinary_bladder | 1.12287880 |
77 | MP0003136_yellow_coat_color | 1.10556220 |
78 | MP0005409_darkened_coat_color | 1.10105023 |
79 | MP0000467_abnormal_esophagus_morphology | 1.08982598 |
80 | MP0002066_abnormal_motor_capabilities/c | 1.08947311 |
81 | MP0003861_abnormal_nervous_system | 1.07839339 |
82 | MP0004924_abnormal_behavior | 1.07008397 |
83 | MP0005386_behavior/neurological_phenoty | 1.07008397 |
84 | MP0001529_abnormal_vocalization | 1.06810532 |
85 | MP0000537_abnormal_urethra_morphology | 1.06438431 |
86 | MP0002233_abnormal_nose_morphology | 1.06278752 |
87 | MP0001216_abnormal_epidermal_layer | 1.05442049 |
88 | MP0000566_synostosis | 1.03622203 |
89 | MP0002909_abnormal_adrenal_gland | 1.03152092 |
90 | MP0000751_myopathy | 1.00847075 |
91 | MP0002098_abnormal_vibrissa_morphology | 1.00747455 |
92 | MP0003119_abnormal_digestive_system | 1.00631328 |
93 | MP0004142_abnormal_muscle_tone | 1.00276757 |
94 | MP0003890_abnormal_embryonic-extraembry | 0.98613829 |
95 | MP0000955_abnormal_spinal_cord | 0.98542222 |
96 | MP0000631_abnormal_neuroendocrine_gland | 0.97534269 |
97 | MP0000579_abnormal_nail_morphology | 0.96465333 |
98 | MP0003937_abnormal_limbs/digits/tail_de | 0.95440040 |
99 | MP0005646_abnormal_pituitary_gland | 0.94258041 |
100 | MP0003315_abnormal_perineum_morphology | 0.94154931 |
101 | MP0000647_abnormal_sebaceous_gland | 0.92519857 |
102 | MP0002152_abnormal_brain_morphology | 0.89985958 |
103 | MP0000427_abnormal_hair_cycle | 0.89870327 |
104 | MP0001299_abnormal_eye_distance/ | 0.89371033 |
105 | MP0000026_abnormal_inner_ear | 0.88157173 |
106 | MP0010386_abnormal_urinary_bladder | 0.87064087 |
107 | MP0001188_hyperpigmentation | 0.84451703 |
108 | MP0002069_abnormal_eating/drinking_beha | 0.83242471 |
109 | MP0003567_abnormal_fetal_cardiomyocyte | 0.82985184 |
110 | MP0005360_urolithiasis | 0.82827140 |
111 | MP0003137_abnormal_impulse_conducting | 0.81933896 |
112 | MP0002249_abnormal_larynx_morphology | 0.81337839 |
113 | MP0004742_abnormal_vestibular_system | 0.81153874 |
114 | MP0001177_atelectasis | 0.81146337 |
115 | MP0005195_abnormal_posterior_eye | 0.80938661 |
116 | MP0003755_abnormal_palate_morphology | 0.80772091 |
117 | MP0008874_decreased_physiological_sensi | 0.80390135 |
118 | MP0003787_abnormal_imprinting | 0.80295107 |
119 | MP0002090_abnormal_vision | 0.77239164 |
120 | MP0003385_abnormal_body_wall | 0.76730826 |
121 | MP0002229_neurodegeneration | 0.75855773 |
122 | MP0001963_abnormal_hearing_physiology | 0.75633509 |
123 | MP0002876_abnormal_thyroid_physiology | 0.75577141 |
124 | MP0003638_abnormal_response/metabolism_ | 0.75159007 |
125 | MP0010678_abnormal_skin_adnexa | 0.75005959 |
126 | MP0002752_abnormal_somatic_nervous | 0.74836254 |
127 | MP0005391_vision/eye_phenotype | 0.73530411 |
128 | MP0001346_abnormal_lacrimal_gland | 0.73405460 |
129 | MP0004147_increased_porphyrin_level | 0.73224404 |
130 | MP0008877_abnormal_DNA_methylation | 0.72983824 |
131 | MP0006035_abnormal_mitochondrial_morpho | 0.72120792 |
132 | MP0001986_abnormal_taste_sensitivity | 0.72092369 |
133 | MP0004484_altered_response_of | 0.71583474 |
134 | MP0005367_renal/urinary_system_phenotyp | 0.71324042 |
135 | MP0000516_abnormal_urinary_system | 0.71324042 |
136 | MP0001340_abnormal_eyelid_morphology | 0.69463432 |
137 | MP0001664_abnormal_digestion | 0.68198289 |
138 | MP0004215_abnormal_myocardial_fiber | 0.68195147 |
139 | MP0003633_abnormal_nervous_system | 0.67184183 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 5.57689701 |
2 | Increased circulating renin level (HP:0000848) | 4.74209280 |
3 | Hyperventilation (HP:0002883) | 4.29629408 |
4 | Metabolic alkalosis (HP:0200114) | 4.10973460 |
5 | Focal seizures (HP:0007359) | 4.07465076 |
6 | Hyperactive renin-angiotensin system (HP:0000841) | 4.06332416 |
7 | Epileptic encephalopathy (HP:0200134) | 4.02268831 |
8 | Gait imbalance (HP:0002141) | 3.85546294 |
9 | Polyphagia (HP:0002591) | 3.82212748 |
10 | Myokymia (HP:0002411) | 3.78326888 |
11 | Hypokalemic alkalosis (HP:0001949) | 3.64853956 |
12 | Hypomagnesemia (HP:0002917) | 3.56617374 |
13 | Visual hallucinations (HP:0002367) | 3.50894611 |
14 | Congenital primary aphakia (HP:0007707) | 3.49466224 |
15 | Absence seizures (HP:0002121) | 3.35046813 |
16 | Cortical dysplasia (HP:0002539) | 3.32104642 |
17 | Broad-based gait (HP:0002136) | 3.32029964 |
18 | Medial flaring of the eyebrow (HP:0010747) | 3.30138985 |
19 | Nephrogenic diabetes insipidus (HP:0009806) | 3.23344252 |
20 | Polyuria (HP:0000103) | 3.22635899 |
21 | Gout (HP:0001997) | 3.11271779 |
22 | Abnormal eating behavior (HP:0100738) | 3.10404803 |
23 | Hypotrichosis (HP:0001006) | 3.08029304 |
24 | Atonic seizures (HP:0010819) | 3.05181371 |
25 | Abnormality of chloride homeostasis (HP:0011422) | 3.03386659 |
26 | Shoulder girdle muscle weakness (HP:0003547) | 3.01514364 |
27 | Progressive cerebellar ataxia (HP:0002073) | 2.99903598 |
28 | Parakeratosis (HP:0001036) | 2.97260801 |
29 | Dialeptic seizures (HP:0011146) | 2.91070997 |
30 | Abnormal urine output (HP:0012590) | 2.90565616 |
31 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.87440472 |
32 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.87440472 |
33 | Abnormal drinking behavior (HP:0030082) | 2.84182725 |
34 | Polydipsia (HP:0001959) | 2.84182725 |
35 | Cerebral inclusion bodies (HP:0100314) | 2.78938698 |
36 | Febrile seizures (HP:0002373) | 2.77412941 |
37 | Abnormality of renin-angiotensin system (HP:0000847) | 2.77405853 |
38 | Abnormality of magnesium homeostasis (HP:0004921) | 2.75930088 |
39 | Abnormality of the labia minora (HP:0012880) | 2.75383812 |
40 | Abnormality of renal excretion (HP:0011036) | 2.74311926 |
41 | Urinary urgency (HP:0000012) | 2.73546623 |
42 | Genital tract atresia (HP:0001827) | 2.73287306 |
43 | Vaginal atresia (HP:0000148) | 2.73132264 |
44 | Generalized tonic-clonic seizures (HP:0002069) | 2.71057727 |
45 | Abnormality of secondary sexual hair (HP:0009888) | 2.68782355 |
46 | Abnormality of the axillary hair (HP:0100134) | 2.68782355 |
47 | Specific learning disability (HP:0001328) | 2.66187290 |
48 | Excessive salivation (HP:0003781) | 2.65945771 |
49 | Drooling (HP:0002307) | 2.65945771 |
50 | Septo-optic dysplasia (HP:0100842) | 2.62748524 |
51 | Split foot (HP:0001839) | 2.60291292 |
52 | Retinal dysplasia (HP:0007973) | 2.59971151 |
53 | Obstructive sleep apnea (HP:0002870) | 2.59669382 |
54 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.59324672 |
55 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.59324672 |
56 | Lissencephaly (HP:0001339) | 2.56949393 |
57 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.55099908 |
58 | Hyperaldosteronism (HP:0000859) | 2.54534084 |
59 | Abnormality of the corticospinal tract (HP:0002492) | 2.52389554 |
60 | Amblyopia (HP:0000646) | 2.50236071 |
61 | Optic nerve hypoplasia (HP:0000609) | 2.49955393 |
62 | Neurofibrillary tangles (HP:0002185) | 2.48890710 |
63 | Spastic gait (HP:0002064) | 2.45246175 |
64 | Partial agenesis of the corpus callosum (HP:0001338) | 2.41754122 |
65 | Poor coordination (HP:0002370) | 2.38775976 |
66 | Unilateral renal agenesis (HP:0000122) | 2.37683997 |
67 | Pelvic girdle muscle weakness (HP:0003749) | 2.33871048 |
68 | Poor suck (HP:0002033) | 2.30984114 |
69 | Exotropia (HP:0000577) | 2.29986442 |
70 | Hepatoblastoma (HP:0002884) | 2.25208067 |
71 | Epileptiform EEG discharges (HP:0011182) | 2.23508379 |
72 | Supranuclear gaze palsy (HP:0000605) | 2.22916653 |
73 | Diplopia (HP:0000651) | 2.21876478 |
74 | Abnormality of binocular vision (HP:0011514) | 2.21876478 |
75 | Colon cancer (HP:0003003) | 2.20637099 |
76 | Fetal akinesia sequence (HP:0001989) | 2.20204506 |
77 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.20120614 |
78 | True hermaphroditism (HP:0010459) | 2.19403184 |
79 | Failure to thrive in infancy (HP:0001531) | 2.16296783 |
80 | Broad foot (HP:0001769) | 2.16223786 |
81 | Lower limb muscle weakness (HP:0007340) | 2.16176394 |
82 | Decreased testicular size (HP:0008734) | 2.15747900 |
83 | Fragile nails (HP:0001808) | 2.15718214 |
84 | Pachygyria (HP:0001302) | 2.15077199 |
85 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.14991080 |
86 | Hypoplasia of the brainstem (HP:0002365) | 2.14991080 |
87 | Labial hypoplasia (HP:0000066) | 2.12488143 |
88 | Postaxial hand polydactyly (HP:0001162) | 2.12186415 |
89 | Papillary thyroid carcinoma (HP:0002895) | 2.11720482 |
90 | Amyotrophic lateral sclerosis (HP:0007354) | 2.07867803 |
91 | Absent eyebrow (HP:0002223) | 2.06370806 |
92 | Akinesia (HP:0002304) | 2.06360724 |
93 | Inability to walk (HP:0002540) | 2.06252652 |
94 | Limb dystonia (HP:0002451) | 2.05922044 |
95 | Spastic tetraplegia (HP:0002510) | 2.03733914 |
96 | Abnormality of the lower motor neuron (HP:0002366) | 2.03672440 |
97 | EEG with generalized epileptiform discharges (HP:0011198) | 2.03480317 |
98 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.03452097 |
99 | Oligodontia (HP:0000677) | 2.03105364 |
100 | Plantar hyperkeratosis (HP:0007556) | 2.02956537 |
101 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.02250555 |
102 | Hyperthyroidism (HP:0000836) | 2.01268870 |
103 | Renal salt wasting (HP:0000127) | 2.00537712 |
104 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.99357996 |
105 | Alkalosis (HP:0001948) | 1.99044877 |
106 | Anxiety (HP:0000739) | 1.97171711 |
107 | Esotropia (HP:0000565) | 1.96680714 |
108 | Thyroid-stimulating hormone excess (HP:0002925) | 1.96592351 |
109 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.96275145 |
110 | Morphological abnormality of the middle ear (HP:0008609) | 1.94503185 |
111 | Dysdiadochokinesis (HP:0002075) | 1.94432016 |
112 | Pancreatic cysts (HP:0001737) | 1.94086783 |
113 | Hypoplasia of the corpus callosum (HP:0002079) | 1.93868946 |
114 | Hip dysplasia (HP:0001385) | 1.93729172 |
115 | Agitation (HP:0000713) | 1.93711691 |
116 | Abnormality of salivation (HP:0100755) | 1.93468003 |
117 | Paraplegia (HP:0010550) | 1.93218883 |
118 | Conjunctival hamartoma (HP:0100780) | 1.92615466 |
119 | Concave nail (HP:0001598) | 1.92430770 |
120 | Micropenis (HP:0000054) | 1.92244809 |
121 | Absent speech (HP:0001344) | 1.91957216 |
122 | Hypercalciuria (HP:0002150) | 1.91014474 |
123 | Tubular atrophy (HP:0000092) | 1.90933142 |
124 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.90762243 |
125 | Abnormality of midbrain morphology (HP:0002418) | 1.90673432 |
126 | Molar tooth sign on MRI (HP:0002419) | 1.90673432 |
127 | Narrow forehead (HP:0000341) | 1.89246102 |
128 | Hypsarrhythmia (HP:0002521) | 1.88375628 |
129 | Tetany (HP:0001281) | 1.88332834 |
130 | Poor eye contact (HP:0000817) | 1.88296634 |
131 | Pancreatic fibrosis (HP:0100732) | 1.87297258 |
132 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.87055901 |
133 | Advanced eruption of teeth (HP:0006288) | 1.85657106 |
134 | Pendular nystagmus (HP:0012043) | 1.84798790 |
135 | Nephronophthisis (HP:0000090) | 1.84513777 |
136 | Sleep apnea (HP:0010535) | 1.83766063 |
137 | Short tibia (HP:0005736) | 1.83323222 |
138 | Hypoplastic female external genitalia (HP:0012815) | 1.83151980 |
139 | Pheochromocytoma (HP:0002666) | 1.82326573 |
140 | Ankle clonus (HP:0011448) | 1.81721402 |
141 | Abnormal social behavior (HP:0012433) | 1.81514051 |
142 | Impaired social interactions (HP:0000735) | 1.81514051 |
143 | Aqueductal stenosis (HP:0002410) | 1.80305745 |
144 | Intestinal atresia (HP:0011100) | 1.79410829 |
145 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.78636936 |
146 | Lip pit (HP:0100267) | 1.77530443 |
147 | Palmoplantar hyperkeratosis (HP:0000972) | 1.77032323 |
148 | Occipital encephalocele (HP:0002085) | 1.76239747 |
149 | Astrocytoma (HP:0009592) | 1.75170321 |
150 | Abnormality of the astrocytes (HP:0100707) | 1.75170321 |
151 | Muscular hypotonia of the trunk (HP:0008936) | 1.74764994 |
152 | Mutism (HP:0002300) | 1.74658050 |
153 | Ketoacidosis (HP:0001993) | 1.74035761 |
154 | Gastroesophageal reflux (HP:0002020) | 1.73827527 |
155 | Spastic paraplegia (HP:0001258) | 1.73077418 |
156 | Hypocalcemia (HP:0002901) | 1.72281356 |
157 | Increased purine levels (HP:0004368) | 1.72249324 |
158 | Hyperuricemia (HP:0002149) | 1.72249324 |
159 | Insidious onset (HP:0003587) | 1.71782090 |
160 | Termporal pattern (HP:0011008) | 1.71782090 |
161 | Dehydration (HP:0001944) | 1.71442085 |
162 | Generalized myoclonic seizures (HP:0002123) | 1.69539905 |
163 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.69522404 |
164 | Progressive inability to walk (HP:0002505) | 1.69306453 |
165 | Absent septum pellucidum (HP:0001331) | 1.68626623 |
166 | Hemiparesis (HP:0001269) | 1.68345816 |
167 | Severe Myopia (HP:0011003) | 1.67698734 |
168 | Decreased circulating renin level (HP:0003351) | 1.66369586 |
169 | Natal tooth (HP:0000695) | 1.64274074 |
170 | Truncal ataxia (HP:0002078) | 1.63871179 |
171 | Action tremor (HP:0002345) | 1.63449730 |
172 | Gaze-evoked nystagmus (HP:0000640) | 1.63445881 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CASK | 4.05540399 |
2 | MARK1 | 3.92390422 |
3 | NTRK3 | 3.47320686 |
4 | MAP3K12 | 3.28523097 |
5 | EPHA4 | 3.26237517 |
6 | WNK3 | 3.10489107 |
7 | MST1R | 2.98778006 |
8 | OXSR1 | 2.77336577 |
9 | MAP3K9 | 2.63156979 |
10 | TRIM28 | 2.57515903 |
11 | NTRK2 | 2.49857441 |
12 | EPHB2 | 2.48061491 |
13 | MINK1 | 2.39521968 |
14 | MAP3K4 | 2.35202287 |
15 | WNK4 | 2.24547824 |
16 | MAP4K2 | 2.02744868 |
17 | RIPK4 | 1.98588852 |
18 | MAP2K4 | 1.88814435 |
19 | CSNK1A1L | 1.85112115 |
20 | SRPK1 | 1.78590072 |
21 | EPHA3 | 1.77487135 |
22 | DYRK3 | 1.75260630 |
23 | MAP2K7 | 1.70471556 |
24 | KSR1 | 1.69448743 |
25 | ERBB3 | 1.60316170 |
26 | PINK1 | 1.59173356 |
27 | RPS6KA4 | 1.58795073 |
28 | GRK5 | 1.51282566 |
29 | UHMK1 | 1.49522369 |
30 | SIK3 | 1.46693348 |
31 | CSNK1G1 | 1.46257868 |
32 | CDK19 | 1.45528384 |
33 | PLK2 | 1.43403510 |
34 | MAPK13 | 1.37321287 |
35 | MAP3K2 | 1.35429705 |
36 | BCKDK | 1.34859310 |
37 | FER | 1.32490715 |
38 | DYRK2 | 1.21166590 |
39 | BCR | 1.19223362 |
40 | FRK | 1.18134680 |
41 | CDK5 | 1.16156191 |
42 | PAK6 | 1.13550387 |
43 | DAPK2 | 1.07218791 |
44 | STK39 | 1.02648381 |
45 | DAPK1 | 1.01912472 |
46 | DYRK1B | 1.01750207 |
47 | PRPF4B | 1.00995277 |
48 | GRK7 | 1.00826184 |
49 | BMPR1B | 0.97447192 |
50 | PRKCG | 0.96850143 |
51 | CAMK2A | 0.96355618 |
52 | SGK494 | 0.93747816 |
53 | SGK223 | 0.93747816 |
54 | CAMKK2 | 0.93717986 |
55 | PNCK | 0.89940193 |
56 | FGR | 0.88060824 |
57 | SIK2 | 0.87288710 |
58 | PDK3 | 0.86902627 |
59 | PDK4 | 0.86902627 |
60 | PAK3 | 0.83719000 |
61 | BMPR2 | 0.83695150 |
62 | DYRK1A | 0.83497525 |
63 | FGFR2 | 0.83408980 |
64 | PHKG2 | 0.80123598 |
65 | PHKG1 | 0.80123598 |
66 | TNIK | 0.79357229 |
67 | CDC42BPA | 0.78471497 |
68 | NTRK1 | 0.72828476 |
69 | PRKD3 | 0.72155695 |
70 | MARK2 | 0.70700596 |
71 | SGK1 | 0.69710779 |
72 | STK11 | 0.69480224 |
73 | CAMK4 | 0.69446787 |
74 | LATS2 | 0.69410182 |
75 | CSNK1G2 | 0.69182111 |
76 | PRKCE | 0.69140886 |
77 | CDK18 | 0.68028796 |
78 | KSR2 | 0.67819858 |
79 | TYRO3 | 0.67298538 |
80 | INSRR | 0.65710235 |
81 | MKNK1 | 0.65369115 |
82 | BRD4 | 0.64343924 |
83 | MST4 | 0.64090053 |
84 | BRSK1 | 0.62572533 |
85 | CDK14 | 0.61509889 |
86 | CDK15 | 0.59896132 |
87 | ADRBK1 | 0.58712748 |
88 | CDK3 | 0.58441077 |
89 | SGK2 | 0.57531904 |
90 | CAMK2B | 0.56871620 |
91 | STK38L | 0.55865851 |
92 | VRK1 | 0.55139841 |
93 | CCNB1 | 0.54483495 |
94 | MAP3K5 | 0.53789850 |
95 | MAPKAPK3 | 0.53413853 |
96 | CDK11A | 0.51396749 |
97 | TAOK1 | 0.51142096 |
98 | PRKCZ | 0.50291838 |
99 | TESK1 | 0.49763447 |
100 | PKN1 | 0.49139666 |
101 | FES | 0.47529183 |
102 | LIMK1 | 0.46687792 |
103 | PTK2B | 0.45219799 |
104 | NME1 | 0.44506460 |
105 | MKNK2 | 0.43336021 |
106 | TSSK6 | 0.42228542 |
107 | ROCK2 | 0.41224166 |
108 | MAP3K6 | 0.40578771 |
109 | CSNK1A1 | 0.40539840 |
110 | CAMKK1 | 0.39937042 |
111 | CAMK2G | 0.39902210 |
112 | CSNK1D | 0.39603641 |
113 | CAMK1 | 0.39571354 |
114 | GRK6 | 0.36839544 |
115 | MET | 0.36747663 |
116 | RPS6KA5 | 0.36607579 |
117 | GRK1 | 0.36089971 |
118 | PRKACB | 0.36082353 |
119 | RPS6KA2 | 0.35232368 |
120 | MAPK12 | 0.35157474 |
121 | ADRBK2 | 0.34797813 |
122 | AKT3 | 0.34749485 |
123 | PRKACA | 0.33975684 |
124 | CSNK1G3 | 0.33839328 |
125 | PLK3 | 0.33668576 |
126 | FYN | 0.33493927 |
127 | LATS1 | 0.32330196 |
128 | PRKCI | 0.30102375 |
129 | PDK2 | 0.30101817 |
130 | PRKAA1 | 0.29839797 |
131 | PRKCA | 0.29823312 |
132 | MAPK9 | 0.29675053 |
133 | STK24 | 0.29506114 |
134 | AURKA | 0.29412942 |
135 | ERBB4 | 0.29386394 |
136 | RET | 0.29375961 |
137 | STK38 | 0.29322977 |
138 | MAP3K7 | 0.29189342 |
139 | CSNK1E | 0.29094148 |
140 | PIM2 | 0.27717051 |
141 | TIE1 | 0.27473534 |
142 | PKN2 | 0.27028671 |
143 | MAPKAPK5 | 0.25453961 |
144 | PRKG1 | 0.25346867 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.66901804 |
2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.06584292 |
3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.94120081 |
4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.92708444 |
5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.75930891 |
6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.36158515 |
7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.28198126 |
8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.19990177 |
9 | Protein export_Homo sapiens_hsa03060 | 2.19278913 |
10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.15076682 |
11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.14883307 |
12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.14371822 |
13 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.99451773 |
14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.99398005 |
15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.94607863 |
16 | Salivary secretion_Homo sapiens_hsa04970 | 1.91332721 |
17 | Morphine addiction_Homo sapiens_hsa05032 | 1.89639300 |
18 | Renin secretion_Homo sapiens_hsa04924 | 1.85588026 |
19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.85071183 |
20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85045370 |
21 | Taste transduction_Homo sapiens_hsa04742 | 1.82827052 |
22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.76898224 |
23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.76436854 |
24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.74108707 |
25 | Axon guidance_Homo sapiens_hsa04360 | 1.71908027 |
26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.65316118 |
27 | Long-term depression_Homo sapiens_hsa04730 | 1.63599227 |
28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.56067599 |
29 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.49267862 |
30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.43587552 |
31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.41584334 |
32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41361841 |
33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.36657640 |
34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.31294697 |
35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30436009 |
36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.27089919 |
37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.24350931 |
38 | Insulin secretion_Homo sapiens_hsa04911 | 1.22735947 |
39 | Gap junction_Homo sapiens_hsa04540 | 1.18566701 |
40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.16071651 |
41 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.15811193 |
42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13923095 |
43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.13692497 |
44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.12722040 |
45 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12238283 |
46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11272586 |
47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11151511 |
48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10732693 |
49 | Phototransduction_Homo sapiens_hsa04744 | 1.09906329 |
50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.07843351 |
51 | Circadian rhythm_Homo sapiens_hsa04710 | 1.02453927 |
52 | Melanogenesis_Homo sapiens_hsa04916 | 1.01001986 |
53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98761104 |
54 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.94841230 |
55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.94536287 |
56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89544500 |
57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87157301 |
58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85945679 |
59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85780003 |
60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85403487 |
61 | Alcoholism_Homo sapiens_hsa05034 | 0.84391018 |
62 | Parkinsons disease_Homo sapiens_hsa05012 | 0.84389694 |
63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82763088 |
64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76330824 |
65 | Glioma_Homo sapiens_hsa05214 | 0.74767825 |
66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74663750 |
67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73461044 |
68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69557216 |
69 | Peroxisome_Homo sapiens_hsa04146 | 0.69300972 |
70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64660006 |
71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64457872 |
72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63109325 |
73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63025092 |
74 | Mineral absorption_Homo sapiens_hsa04978 | 0.62991208 |
75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.59638063 |
76 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.59383070 |
77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58643849 |
78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55683228 |
79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54796511 |
80 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.53826020 |
81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.52781138 |
82 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.51948111 |
83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51390206 |
84 | RNA degradation_Homo sapiens_hsa03018 | 0.51067399 |
85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50358867 |
86 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49860194 |
87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49524584 |
88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49170747 |
89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48994158 |
90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48835528 |
91 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48225681 |
92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47308349 |
93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47288766 |
94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47242101 |
95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46949201 |
96 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46701174 |
97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46344636 |
98 | Spliceosome_Homo sapiens_hsa03040 | 0.45747389 |
99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45716529 |
100 | Phagosome_Homo sapiens_hsa04145 | 0.44381839 |
101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43402046 |
102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43088643 |
103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41951629 |
104 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41648892 |
105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40531367 |
106 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.40131982 |
107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.39742504 |
108 | Bile secretion_Homo sapiens_hsa04976 | 0.39695969 |
109 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39265731 |
110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39142317 |
111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.39123071 |
112 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.36596738 |
113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36555646 |
114 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35828615 |
115 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.35665231 |
116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35087625 |
117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.34812211 |
118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34240108 |
119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33789700 |
120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33649969 |
121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33384153 |
122 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.33292487 |
123 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32767767 |
124 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.32502792 |
125 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32445218 |
126 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31724378 |
127 | RNA transport_Homo sapiens_hsa03013 | 0.31697406 |
128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31590156 |
129 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.31303324 |
130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30651196 |
131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30640791 |
132 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30358118 |
133 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.30244735 |
134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30008036 |
135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.27898018 |
136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27047056 |
137 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.26921020 |